NCT06683846
- Conditions
- Adenocarcinoma, Adrenal Cortical Cancer, Angiomyolipoma, +56 more
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Renal Angiomyolipoma
Explore clinical trials studying Renal Angiomyolipoma. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Renal Angiomyolipoma trial results
NCT03525834
- Conditions
- Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
- Locations
-
- Novartis Investigative Site Wuhan, Hubei, China
- Novartis Investigative Site Shanghai, Shanghai Municipality, China
- Novartis Investigative Site Chengdu, Sichuan, China
- Novartis Investigative Site Beijing, China
Active, Not Recruiting
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)
NCT05252585
- Conditions
- Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
- Locations
-
- Novartis Investigative Site Taichung, Taiwan ROC, Taiwan
- Novartis Investigative Site Taoyuan, Taiwan ROC, Taiwan
- Novartis Investigative Site Taipei, Taiwan
- Novartis Investigative Site Taoyuan, Taiwan
Active, Not Recruiting
Evaluation of a Simple-Prep Controlled Embolic
NCT06453642
- Conditions
- Adenocarcinoma, Angiomyolipoma, Bone Diseases, +30 more
- Locations
-
- University of California San Diego Altman Clinical and Translation Research Institute La Jolla, California, United States
- University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
- Northwestern University Chicago, Illinois, United States
- Indiana University Hospital Indianapolis, Indiana, United States